Organisation: Paxil

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

Pádraig Hoare: The Monday Interview - Big pharma talks up its local roots

GSK in Dungarvan produces more than six billion tablets for the global market every year. Country manager of GSK Consumer Healthcare Ireland, Dave Barrett tells Pádraig Hoare why its Irish plants are key

news

Seroxat study ‘failed’ to report effects

business

Pharma giant to pay $3bn in healthcare fraud case

Anti-depressant drugs - Investigate claimed link to suicides

business

Drugs giant Glaxo sees pre-tax profits slide 17% to £1.63 billion

business

GSK posts 17% fall in half-year profits

GSK facing lawsuit over drug for children

British pharmaceuticals giant GlaxoSmithKline was hit with a multi-million pound lawsuit today after allegedly misleading doctors about the safety of an anti-depressant drug for children.

Wed, 02 Jun, 2004

US warning on antidepressants

Patients on some popular antidepressants should be closely monitored for warning signs of suicide, the US government warned today in asking the makers of 10 drugs to add the caution to their labels.

Mon, 22 Mar, 2004

GlaxoSmithKline profits rise 14%

GlaxoSmithKline has reported a 14% rise in pre-tax profits to £6.7bn (€9.88bn) despite a 40% fall in sales of bestselling antidepressant Paxil.

Thu, 12 Feb, 2004

GlaxoSmithKline lose patent battle

Pharmaceuticals giant GlaxoSmithKline today said it had lost a key court case in the US over the patent to its anti-depressant Paxil.

Tue, 04 Mar, 2003

No suprises in store from GlaxoSmithKline, say analysts

Analysts are expecting few surprises when GlaxoSmithKline reveals its first quarter results tomorrow.

Mon, 23 Apr, 2001